The seventieth anniversary of the hormonal treatment of prostatic carcinoma | Zendy

Lela Milovanovic | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The seventieth anniversary of the hormonal treatment of prostatic carcinoma

Author(s) -

Lela Milovanovic

Publication year - 2011

Publication title -

archive of oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.104

H-Index - 13

eISSN - 1450-9520

pISSN - 0354-7310

DOI - 10.2298/aoo1102028m

Subject(s) - antiandrogens , hormonal therapy , medicine , hormone , cancer , carcinoma , orchiectomy , oncology , prostate cancer , antiandrogen , androgen

Hormonal treatment of prostatic carcinoma was initiated in the first half of twentieth century. Theoretical basis of hormonal treatment was established with the work of Charles Brenton Huggins published in 1941. Initial results were encouraging, but fatal outcome occurred anyway. There are four directions of hormonal treatment of pancreatic cancer: orchiectomy, estrogens, LHRH agonists, or antiandrogens. Refinements of hormonal therapy were constant and resulted in prolonged survival time and fairly improved quality of life. These results rank hormonal therapy of pancreatic cancer as the most successful systemic treatment of metastatic disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research